Close

Form 10-K/A NOVAVAX INC For: Dec 31

April 30, 2021 6:13 AM EDT

Exhibit 31.3

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

I, Stanley C. Erck, certify that:

 

1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of Novavax, Inc.; and

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: April 29, 2021 By: /s/ Stanley C. Erck
    Stanley C. Erck
    President and Chief Executive Officer

 

 

 

Exhibit 31.4

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

I, John J. Trizzino, certify that:

 

1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of Novavax, Inc.; and

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: April 29, 2021 By: /s/ John J. Trizzino
    John J. Trizzino
    Executive Vice President, Chief Commercial Officer, Chief Business Officer and Interim Chief Financial Officer

 

 

 



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings